U.S. pharma big copyright scrapped two experimental weight loss pills final calendar year—a as soon as-everyday pill, lotiglipron, as a consequence of elevated liver enzymes plus a 2 times-every day capsule, danuglipron, as a consequence of robust side effects—but CEO Albert Bourla has mentioned the company is determined to “Participate in an